A retrospective prognostic evaluation using unsupervised learning in the treatment of COVID-19 patients with hypertension treated with ACEI/ARB drugsCOVID-19 Published on 2024-05-132024-09-05 Journal: PeerJ [Category] update2024, [키워드] ACEi ARB COVID-19 hypertension prognostic evaluation unsupervised learning [DOI] 10.7717/peerj.17340 PMC 바로가기 [Article Type] COVID-19
Angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers and hemorrhoids: A nationwide, population-based study4400 Published on 2023-06-022024-09-05 Journal: Medicine [Category] update2024, [키워드] ACEi ARB hemorrhoid [DOI] 10.1097/MD.0000000000033875 PMC 바로가기 [Article Type] 4400
Renin-angiotensin system blocker and the COVID-19 aggravation in patients with hypertension, diabetes, renal failure, Cerebro-cardiovascular disease, or pulmonary disease: Report by the COVID-19 Registry JapanObservational Study Published on 2022-10-012022-10-05 Journal: Journal of cardiology [Category] 임상, [키워드] ACEi/ARB acute respiratory syndrome Admission Analysis angiotensin-converting enzyme inhibitor ARB Associated factors association blocker chronic obstructive COPD coronavirus coronavirus disease correlation COVID-19 diabetes Diabetes Mellitus disease Disease outcome. Diseases enrolled extracorporeal membrane oxygenation Factor Female patients healthcare healthcare facility hypertension In-hospital death increased risk information intensive care Japan lower risk male Male sex outcome pandemic Patient patients positive Primary outcome Primary outcomes pulmonary disease receptor registry registry data renal renal impairment report risk severe COVID-19 severe renal impairment severity Support Treatment ventilator with COVID-19 [DOI] 10.1016/j.jjcc.2022.04.001 PMC 바로가기 [Article Type] Observational Study
Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19COVID-19로 입원한 남성의 개선된 결과와 관련된 레닌-안지오텐신 시스템 경로 치료제Observational Study Published on 2022-09-012022-09-11 Journal: Critical Care Medicine [Category] 유전자 메커니즘, 임상, [키워드] ACE ACE inhibitor ACE inhibitors ACE-2 ACE2 gene acute COVID-19 acute COVID-19 illness acute respiratory syndrome acute respiratory syndrome coronavirus adjusted odds ratio Admission Analysis angiotensin Angiotensin II angiotensin receptor blocker Angiotensin receptor blockers Angiotensin-converting enzyme ARB ARBs baseline baseline characteristics cohort of patient Comorbidities component components contribute coronavirus COVID-19 COVID-19 illness d -dimer determine downregulate dysregulation Effect explain female females hospital Hospitalized hospitalized patient hospitalized patients Improved include inhibitor inhibitors Interaction less male measurement Mortality multicenter Observational cohort study organ support outcome outcomes Patient plasma polymerase chain polymerase chain reaction pro-inflammatory Prospective RAS recorded Renin renin-angiotensin system response severe acute respiratory syndrome Coronavirus Sex Sex-related differences significant effect significantly significantly higher System Therapeutics Treatment Vasopressor vasopressors Ventilation with COVID-19 X chromosome [DOI] 10.1097/CCM.0000000000005589 PMC 바로가기 [Article Type] Observational Study
Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trialRandomized Controlled Trial Published on 2022-07-012022-10-05 Journal: American heart journal [Category] COVID19(2023년), SARS, 유전자 메커니즘, 임상, [키워드] 95% CI ACEi ACEIs angiotensin-converting enzyme inhibitor ARB ARBs baseline blocker Blood oxygen saturation clinical Clinical outcome COVID-19 disease severity days alive diagnosis of COVID-19 Discontinuing disease disease severity had more hospital hospitalized patient insight Lung imaging Mild Moderate COVID-19 no significant difference Patient patients with COVID-19 patients with moderate Primary outcome Randomized receptor the mean Trial with COVID-19 with mild disease [DOI] 10.1016/j.ahj.2022.04.001 PMC 바로가기 [Article Type] Randomized Controlled Trial
Safety of ACEi and ARB in COVID-19 management: A retrospective analysisObservational Study Published on 2022-07-012022-10-05 Journal: Clinical Cardiology [Category] COVID19(2023년), SARS, 임상, [키워드] ACEi ACEi/ARB acute respiratory syndrome Affect Analysis angiotensin receptor blocker Angiotensin-converting enzyme ARB ARBs association clinical guideline complex interplay confounding variable congestive heart failure contagious coronavirus coronavirus disease COVID-19 COVID-19 patient COVID-19 patients enrolled Evidence Factor hospital Host hypertension in-hospital mortality increased mortality individual Inflammatory response Interaction material medication Mortality multicenter multiorgan failure pathway Patient patient data patients Primary outcome regression analysis retrospective Retrospective analysis Safety SARS-CoV2 SARS-CoV2 infection severe COVID-19 severity severity of COVID-19 Society SQL USA variable virus was done were used [DOI] 10.1002/clc.23836 PMC 바로가기 [Article Type] Observational Study
Organ dysfunction and death in patients admitted to hospital with COVID-19 in pandemic waves 1 to 3 in British Columbia, Ontario and Quebec, Canada: a cohort studyObservational Study Published on 2022-04-192022-10-04 Journal: CMAJ open [Category] COVID19(2023년), SARS, 임상, [키워드] 28-day mortality 95% CI 95% confidence interval acute COVID-19 adjusted Admission angiotensin receptor blocker ARB association average baseline characteristics changes in cohort study Community Comorbidity conducted COVID-19 pandemic death demographic characteristics Dexamethasone dysfunction examined excluded hospital Hospital admission IMPROVE in-hospital mortality Invasive mechanical ventilation less Logistic lower mortality management Mortality multicentre Observational cohort study Odds ratio organ support outcome outcomes pandemic Patient Pragmatic readmission Regression model remained renal dysfunction renal replacement therapy RRT severity of illness significantly lower therapy Vasopressor with COVID-19 [DOI] 10.9778/cmajo.20210216 PMC 바로가기 [Article Type] Observational Study
Longitudinal Plasma Proteomics Analysis Reveals Novel Candidate Biomarkers in Acute COVID-19세로형 플라즈마 단백질체학 분석, 급성 코로나19에서 새로운 후보 바이오마커 밝혀Article Published on 2022-04-012022-09-11 Journal: Journal of Proteome Research [Category] MERS, 바이오마커, 유전자 메커니즘, 진단, [키워드] abundance ACEi acquisition Activation acute COVID-19 acute inflammatory response Admission amyloid Analysis angiotensin angiotensin receptor blocker Angiotensin receptor blockers Angiotensin-converting enzyme angiotensin-converting enzyme inhibitors ARB baseline Blood blood plasma candidate cascade cell proliferation complement Complement activation COVID-19 COVID-19 patients decrease degranulation exposure to fluctuation followed by fructose functions healthy control healthy controls healthy individual healthy individuals host response humoral immune response Infection Inflammatory Inflammatory response inhibitors longitudinal longitudinal analysis mechanism mechanisms nonsurvivors novel on admission pathophysiology Patient patients Platelet profile Protein Proteins proteomic proteomics Quantitative Receptor Blockers Regulation smooth muscle survivor targeted quantitative proteomics. [DOI] 10.1021/acs.jproteome.1c00863 PMC 바로가기 [Article Type] Article
The impact of pre-existing hypertension and its treatment on outcomes in patients admitted to hospital with COVID-19 Research Published on 2022-03-292022-10-05 Journal: Hypertension research : official journal of the Ja [Category] COVID19(2023년), SARS, 치료법, [키워드] 95% CI adjusted age analysed Analysis angiotensin receptor blocker anti-hypertensive drug ARB association cardiac disease covariate death enzyme examined hospital hospitalised patient hypertension in-hospital mortality increased risk inhibitor Logistic regression male median age Mortality multivariable novel corona virus occurred Occurrence Older outcome Patient patients hospitalized protective effect SARS-CoV-2 Treatment with COVID-19 [DOI] 10.1038/s41440-022-00893-5 [Article Type] Research
Impact of renin-angiotensin-aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort studyObservational Study Published on 2022-03-232022-10-05 Journal: BMC Public Health [Category] 임상, [키워드] 95% CI ACEi/ARB acute respiratory syndrome adjusted analysed Analysis angiotensin angiotensin receptor blocker Angiotensin receptor blockers angiotensin-converting enzyme inhibitor angiotensin-converting enzyme inhibitors ARB average baseline characteristics clinical Cohort coronavirus country COVID-19 COVID-19 patient COVID-19 patients Cox proportional hazard Critical care Critically ill death discharge enzyme evaluate examined hazard hospital Hospital stay hypertension ICU ICU admission ICUs Impact In-hospital death in-hospital mortality inhibitor intensive care unit International Mortality Observational cohort study Patient patient group prospective cohort study RAAS receptor reduced risk remains uncertain severe acute respiratory syndrome coronavirus 2 survival Trial registration was performed [DOI] 10.1186/s12872-022-02565-1 PMC 바로가기 [Article Type] Observational Study